950,531 Shares in Waystar Holding Corp. $WAY Acquired by Clarkston Capital Partners LLC

Clarkston Capital Partners LLC bought a new stake in shares of Waystar Holding Corp. (NASDAQ:WAY) in the first quarter, Holdings Channel.com reports. The institutional investor bought 950,531 shares of the company’s stock, valued at approximately $22,917,000. Waystar comprises about 1.7% of Clarkston Capital Partners LLC’s investment portfolio, making the stock its 21st biggest position.

Several other institutional investors also recently bought and sold shares of the company. Capricorn Fund Managers Ltd grew its position in shares of Waystar by 46.2% in the 4th quarter. Capricorn Fund Managers Ltd now owns 738,263 shares of the company’s stock valued at $24,178,000 after acquiring an additional 233,141 shares during the period. Renaissance Capital LLC acquired a new stake in Waystar in the 4th quarter valued at about $2,273,000. Fort Washington Investment Advisors Inc. OH bought a new position in Waystar during the fourth quarter worth about $20,987,000. Advisors Preferred LLC acquired a new position in Waystar during the fourth quarter worth approximately $3,975,000. Finally, Louisiana State Employees Retirement System acquired a new position in Waystar during the first quarter worth approximately $1,227,000.

Analyst Upgrades and Downgrades

WAY has been the subject of a number of recent analyst reports. KeyCorp started coverage on Waystar in a research report on Wednesday, July 1st. They issued an “overweight” rating and a $30.00 price objective for the company. Morgan Stanley initiated coverage on Waystar in a research note on Monday, March 30th. They issued an “equal weight” rating and a $28.00 price target on the stock. Bank of America cut their price target on Waystar from $45.00 to $38.00 and set a “buy” rating for the company in a report on Friday, April 10th. Raymond James Financial reaffirmed a “strong-buy” rating and set a $32.00 price objective on shares of Waystar in a research report on Thursday, April 30th. Finally, Barclays lowered their price target on shares of Waystar from $36.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, May 20th. Three investment analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $35.23.

Waystar Stock Performance

Shares of NASDAQ WAY opened at $21.58 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a market cap of $4.14 billion, a price-to-earnings ratio of 32.21, a P/E/G ratio of 0.82 and a beta of 0.08. The stock’s fifty day moving average price is $20.36 and its two-hundred day moving average price is $23.58. Waystar Holding Corp. has a one year low of $17.26 and a one year high of $41.47.

Waystar (NASDAQ:WAY) last posted its earnings results on Wednesday, April 29th. The company reported $0.42 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.03. Waystar had a return on equity of 6.99% and a net margin of 10.90%.The company had revenue of $313.87 million during the quarter, compared to the consensus estimate of $311.74 million. During the same quarter last year, the firm earned $0.32 earnings per share. The company’s revenue was up 22.4% on a year-over-year basis. Waystar has set its FY 2026 guidance at 1.590-1.680 EPS. On average, equities analysts forecast that Waystar Holding Corp. will post 1.46 EPS for the current year.

Waystar Profile

Waystar (NASDAQ:WAY) is a leading provider of cloud-based revenue cycle management and payment solutions for healthcare organizations. The company’s unified platform streamlines the entire financial continuum of patient care, from eligibility verification and claim submission to payment reconciliation and patient billing. By automating key processes and improving claim accuracy, Waystar helps providers reduce administrative overhead, accelerate cash flow and enhance overall revenue performance.

At the core of Waystar’s offering is a SaaS-based architecture that integrates seamlessly with existing electronic health record (EHR) systems and payer networks.